PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4400
-0.0050 (-1.12%)
At close: Dec 19, 2025
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 73.45 million as of December 19, 2025. Its market cap has decreased by -6.51% in one year.
Market Cap
73.45M
Enterprise Value
72.98M
Revenue
17.60M
Ranking
n/a
PE Ratio
272.45
Stock Price
0.44
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 73.45M, an increase of 2,960.32%. That is a compound annual growth rate of 188.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 73.45M | 15.96% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.20B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.18B |
| Extendicare | 2.08B |
| Sienna Senior Living | 2.00B |
| Trulieve Cannabis | 1.97B |
| Cronos Group | 1.55B |
| WELL Health Technologies | 990.54M |